Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stefano Cattunar"'
Autor:
Federico Sanchez, Valentina Boasi, Matteo Vercellino, Chiara Tacchi, Pierpaolo Cannarile, Nicoletta Pingelli, Dino Perri, Laura Gomez, Stefano Cattunar, Giovanni Mascelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) with ticagrelor for more than 12 mont
Externí odkaz:
https://doaj.org/article/f58c70d9ba7a49aca6ed1db97016af2a
Autor:
Matteo Vercellino, Federico Ariel Sànchez, Valentina Boasi, Dino Perri, Chiara Tacchi, Gioel Gabrio Secco, Stefano Cattunar, Gianfranco Pistis, Giovanni Mascelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background European guidelines recommend the use of ticagrelor versus clopidogrel in patients with ST elevation myocardial infarction (STEMI). This recommendation is based on inconclusive results and subanalyses from clinical trials. Few dat
Externí odkaz:
https://doaj.org/article/b9fb1bf2dedf4d16944142f60634d43f
Autor:
Giovanni Mascelli, Stefano Cattunar, Pierpaolo Cannarile, Nicoletta Pingelli, Federico Ariel Sanchez, Laura Gomez, Chiara Tacchi, Dino Perri, Valentina Boasi, Matteo Vercellino
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) with ticagrelor for more than 12 months. It is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1970242632ad69ae6f52a26776b7f4de
https://doi.org/10.1186/s12872-020-01780-y
https://doi.org/10.1186/s12872-020-01780-y
Autor:
Giovanni Mascelli, Gianfranco Pistis, Stefano Cattunar, Chiara Tacchi, Gioel Gabrio Secco, Federico Ariel Sanchez, Dino Perri, Valentina Boasi, Matteo Vercellino
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)
Background European guidelines recommend the use of ticagrelor versus clopidogrel in patients with ST elevation myocardial infarction (STEMI). This recommendation is based on inconclusive results and subanalyses from clinical trials. Few data are ava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f021c83d529d7f5339c41a5bfa5aba71
https://doi.org/10.1186/s12872-017-0524-3
https://doi.org/10.1186/s12872-017-0524-3